Gilead Sciences announced on Monday that it has set a price for Remdesivir, a drug thatβs shown success in reducing the duration of some COVID-19 cases.
India has approved the use of Dexamethasone for moderate and severe Covid cases. Dexamethasone is often used in end-of-life care. This drug is low cost and India has an advantage in production. How..
Remdesivir becomes first COVID-19 drug put forward for use in the EU
![Maker of COVID-19 drug Remdesivir says it will cost about $3,000 per patient [Video]](https://video.newsserve.net/300/v/20200630/2006300313-Maker-of-COVID-19-drug-Remdesivir-says-it.jpg)
![Gilead's Covid-19 Drug Remdesivir To Cost $2,340-$3,120 Per Patient [Video]](https://video.newsserve.net/300/v/20200629/1308689542-Gilead-Covid-19-Drug-Remdesivir-To-Cost.jpg)
![Dexamethasone: What is this life saving treatment which is made in India | Oneindia News [Video]](https://video.newsserve.net/300/v/20200627/1308638898-Dexamethasone-What-is-this-life-saving-treatment-which.jpg)
